Reviv3 Procare Company
OTC:RVIV
0.33 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 23.521 | 2.336 | 1.634 | 1.013 | 0.993 | 0.933 | 0.582 |
| Cost of Revenue
| 5.81 | 0.829 | 0.6 | 0.481 | 0.553 | 0.576 | 0.282 |
| Gross Profit
| 17.711 | 1.508 | 1.034 | 0.532 | 0.44 | 0.357 | 0.3 |
| Gross Profit Ratio
| 0.753 | 0.645 | 0.633 | 0.525 | 0.443 | 0.383 | 0.516 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 4.051 | 0.52 | 0.625 | 0.515 | 0.495 | 0.605 | 0.735 |
| Selling & Marketing Expenses
| 11.675 | 1.199 | 0.73 | 0.188 | 0.094 | 0.091 | 0.104 |
| SG&A
| 15.727 | 1.719 | 1.355 | 0.703 | 0.589 | 0.696 | 0.839 |
| Other Expenses
| 0.017 | 1.719 | 1.355 | 0.245 | 0.228 | 0.696 | 0 |
| Operating Expenses
| 15.727 | 1.719 | 1.355 | 0.703 | 0.589 | 0.696 | 0.839 |
| Operating Income
| 1.984 | -0.211 | -0.321 | -0.171 | -0.15 | -0.339 | -0.538 |
| Operating Income Ratio
| 0.084 | -0.09 | -0.197 | -0.169 | -0.151 | -0.363 | -0.925 |
| Total Other Income Expenses Net
| 0.067 | 0.029 | 0.023 | -0.002 | -0 | -0.004 | -0.001 |
| Income Before Tax
| 2.055 | -0.183 | -0.298 | -0.173 | -0.15 | -0.343 | -0.539 |
| Income Before Tax Ratio
| 0.087 | -0.078 | -0.182 | -0.171 | -0.151 | -0.367 | -0.926 |
| Income Tax Expense
| 0.231 | -0.029 | 0.006 | 0.002 | 0 | 0 | 0 |
| Net Income
| 1.825 | -0.154 | -0.304 | -0.175 | -0.15 | -0.343 | -0.539 |
| Net Income Ratio
| 0.078 | -0.066 | -0.186 | -0.172 | -0.151 | -0.367 | -0.926 |
| EPS
| 0.02 | -0.004 | -0.007 | -0.004 | -0.004 | -0.009 | -0.013 |
| EPS Diluted
| 0.01 | -0.004 | -0.007 | -0.004 | -0.004 | -0.009 | -0.013 |
| EBITDA
| 2.103 | -0.203 | -0.311 | -0.161 | -0.144 | -0.336 | -0.537 |
| EBITDA Ratio
| 0.089 | -0.087 | -0.19 | -0.159 | -0.145 | -0.36 | -0.922 |